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Abstract
A facile method for synthesizing 3,4-dihydropyrimidin-2(1H)-ones and -thiones in the Biginelli reaction by condensation reaction
of aldehydes, -ketoesters and urea or thiourea with p-dodecylbenzenesulfonic acid as a recyclable catalyst under solvent-free
conditions at 80 ◦C is described. A series of indeno[1,2-d]pyrimidines was also synthesized under the same conditions by a Biginelli-
like reaction of 2H-indene-1,3-dione with urea or thiourea and an aromatic aldehyde. All the products in both reactions were obtained
in good to excellent yield by this simple, efficient procedure. The structures of all the synthesized compounds were established from
advanced spectroscopic data.
© 2014 Taibah University. Production and hosting by Elsevier B.V. All rights reserved.
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synthesis1.  Introduction
Multi-component reactions are of increasing impor-
tance in organic and medicinal chemistry as they offer
significant advantages over conventional linear-type syn-
theses [1], including high selectivity, good yields, milder
reaction conditions and simple work-up. Thus, a vast
number of diverse compounds can be obtained in parallel∗ Corresponding author. Tel.: +91 9944093020.
E-mail address: smansoors2000@yahoo.co.in (S.S. Mansoor).
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http://dx.doi.org/10.1016/j.jtusci.2014.03.005syntheses [2]. New, efficient methods for rapid construc-
tion of potentially bio-active compounds are required,
and multi-component reactions allow the construction
of several bonds in a single operation. They are this
gaining in importance as powerful tools for synthesizing
complex, diverse molecules [3].
Biginelli synthesis is an easy multicomponent
reaction used increasingly in organic and medici-
nal chemistry for generating multifunctional products,
including 3,4-dihydropyrimidin-2(1H)-ones and their
thione analogues and related heterocyclic compounds
[4]. Recently, an appropriately functionalized dihy-
dropyrimidine analogue of novel 4-aryl-5-isopropoxy-
carbonyl-6-methyl-3,4-dihydropyrimidinones emerged
as an anti-microbiological agent [5]. A novel 3,4-
dihydropyrimidin-2(1H)-one was reported to inhibit
HIV-1 replication with improved metabolic stability
[6], and its special structure was found to occur natu-
rally in marine alkaloid batzelladines; these are the first
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ow-molecular-mass natural products reported that
nhibit the binding of HIVgp-120 to CD4 cells and
ould thus be a new development in AIDS therapy [7,8].
iginelli synthesis was described in 1893, involving
yclocondensation of ethyl acetoacetate, urea and an
ryl aldehyde in the presence of an acid to produce 3,4-
ihydropyrimidin-2(1H)-ones [9]; however, this reaction
ften requires harsh conditions and long reaction times
nd affords low yields, particularly when substituted
romatic and aliphatic aldehydes are used. The scope
f this reaction was gradually extended by varying
ll three building blocks, allowing the production of
ulti-functionalized dihydropyrimidines of medicinal
se [10].
The most straightforward procedure for preparing
ihydropyrimidinones and thiones is condensation of
-dicarbonyl compounds with an aromatic aldehyde
nd urea or thiourea in the presence of Lewis and
rønsted acid promoters such as silica-immobilized
ickel complex [11], cellulose sulfuric acid [12], lan-
hanum oxide [13], bioglycerol-based sulfonic acid
unctionalized carbon [14], p-sulfonic acid calixarenes
15], copper(II) sulfamate [16], triphenylphosphine [17],
elamine trisulfonic acid [18], montmorillonite KSF
19], natural catalysts [20], hetero-polyacid supported
n zeolite [21], In(OTf)3 [22], ruthenium(III) chloride
23], silica sulfuric acid [24], Nafion-H [25], sulfonated
arbon [26] and lactic acid [27]. The classical Biginelli
eaction is considerably extended by use of 1-indanone
28]. Some of these procedures, however, require expen-
ive reagents, strongly acidic conditions, long reaction
imes, high temperatures or stoichiometric amounts of
atalysts, or they result in environmental pollution or
ive unsatisfactory yields. Therefore, new catalysts are
equired that are readily available or easy to prepare,
nexpensive and recoverable; moreover, the work-up pro-
edure should be simple. Milder, more efficient methods
ith higher yields are therefore needed.
In this regard, p-dodecylbenzenesulfonic acid
DBSA) has found many applications [29–34].
BSA has been used extensively as a Brønsted
cid-surfactant catalyst in Mannich-type reactions
f aldehydes, amines, and ketones [29], ester, ether,
hioether and dithioacetal formation in water [30],
rganic synthesis inside particles in water [31],
olvent-free esterification [32], for the synthesis
f 6-amino-4-aryl-5-cyano-3-methyl-1-phenyl-1,4-
ihydropyrano[2,3-c]pyrazoles in aqueous media [33]
nd for green synthesis of dibenzo[a,j]xanthenes [34].
ts use in the synthesis of 3,4-dihydropyrimidine deriva-
ives and indeno[1,2-d]pyrimidines has not yet been
eported.sity for Science 8 (2014) 236–247 237
In recent years, science and technology has been
moving towards the use of environmentally friendly,
solvent-free conditions in organic synthesis, which has
led in some cases to improved results and more benign
synthetic procedures. Adopting the principles of green
chemistry, we have established that use of solvent-free
conditions for synthesis of 1,4-dihydropyridines results
in a dramatic improvement in yields [35]. As part of
our continuing studies of organic processes on the
development of environmentally friendly procedures
for the synthesis of biologically active heterocyclic
molecules [36–39], we now describe the synthesis
of 3,4-dihydropyrimidine derivatives with DBSA as
an efficient catalyst under solvent-free condition at
80 ◦C. Using the same procedure that we used for the
synthesis of 3,4-dihydropyrimidine derivatives, we
have synthesized a series of 4-aryl-3,4-dihydro-1H-
indeno[1,2-d]pyrimidine-2,5-diones/4-aryl-2-thioxo-
1,2,3,4-tetrahydro-indeno[1,2-d]pyrimidine-5-ones by
the Biginelli-like reaction of 2H-indene-1,3-dione, with
urea or thiourea and aromatic aldehydes.
2.  Materials  and  Methods
2.1.  Chemicals  and  analysis
Chemicals were purchased from Merck, Fluka and
Aldrich Chemical companies. 1H-nuclear magnetic res-
onance (NMR) (500 MHz) and 13C NMR (125 MHz)
spectra were obtained in a Bruker DRX-500 Avance
at ambient temperature, with tetramethylsilane as the
internal standard. Fourier transform infrared (IR) spectra
were obtained as KBr discs on a Shimadzu spectrome-
ter. Mass spectra were determined on a Varion-Saturn
2000 gas chromatograph–mass spectrometer (MS). Ele-
mental analysis was performed on a Perkin Elmer 2400
CHN elemental analyser flowchart. All yields refer to
isolated products unless otherwise stated.
2.2.  General  procedure  for  preparation  of
3,4-dihydropyrimidinones  and  -thiones
A mixture of aldehyde (1 mmol), ethyl acetoac-
etate (1 mmol), urea or thiourea (1.5 mmol) and DBSA
(5 mol%) under solvent-free condition was heated with
stirring at 80 ◦C for the appropriate time. The progress
of the reaction was monitored by thin-layer chromatog-
raphy. After cooling, the reaction mixture was poured
onto crushed ice with stirring. The crude product was
filtered, washed with cold water, dried and recrystallized
from 95% ethanol or ethyl acetate to give pure products.
After separation of the product, CH2Cl2 (20 mL) was
 Univer238 K. Aswin et al. / Journal of Taibah
added, and the catalyst was removed by filtration. The
recovered catalyst was washed twice with fresh CH2Cl2
(2 ×  10 mL), then dried for later runs.
The IR, 1H NMR, 13C NMR, mass and elemen-
tal spectra of the synthesized compounds are given
below.
2.3.  Spectral  data  for  the  synthesized  compounds
(4a–v)
2.3.1.  5-Ethoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-one  (4a)
IR (KBr, cm−1): 3322 and 3213 (N–H str.), 1696
and 1664 (C O str.); 1H NMR (500 MHz, DMSO-
d6) δ: 1.08 (t, J = 7.2 Hz, 3H, OCH2CH3), 2.33 (s,
3H, CH3), 3.92 (q, J = 7.2 Hz, 2H, OCH2CH3), 5.22
(s, 1H, CH), 7.20–7.43 (m, 5H, Ar-H), 7.88 (s, 1H,
NH-1), 9.48 (s, 1H, NH-3) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.1, 17.9, 54.2, 60.1, 100.3, 122.9, 125.7,
129.1, 142.9, 146.1, 154.9, 165.9 ppm; MS(ESI): m/z
261 (M+H)+; Anal. for C14H16N2O3 calculated: C,
64.62; H, 6.15; N, 10.77%; found: C, 64.58; H, 6.13; N,
10.72%.
2.3.2.  5-Ethoxycarbonyl-6-methyl-4-(2-
nitroyphenyl)-3,4-dihydropyrimidin-2(1H)-one  (4b)
IR (KBr, cm−1): 3316 and 3207 (N–H str.), 1698
and 1659 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
1.05 (t, J  = 7.2 Hz, 3H, OCH2CH3), 2.24 (s, 3H, CH3),
3.94 (q, J = 7.2 Hz, 2H, OCH2CH3), 5.20 (s, 1H, CH),
7.00–7.28 (m, 4H, Ar-H), 7.99 (s, 1H, NH-1), 9.20 (s,
1H, NH-3) ppm; 13C NMR (125 MHz, DMSO-d6) δ:
14.8, 17.0, 54.6, 60.7, 100.6, 122.7, 125.5, 129.3, 142.7,
146.3, 154.7, 165.7 ppm; MS(ESI): m/z  306 (M+H)+;
Anal. for C14H15N3O5 calculated: C, 55.08; H, 4.92; N,
13.77%; found: C, 55.00; H, 4.94; N, 13.70%.
2.3.3.  5-Ethoxycarbonyl-6-methyl-4-(4-
ﬂuorophenyl)-3,4-dihydropyrimidin-2(1H)-one  (4c)
IR (KBr, cm−1): 3321 and 3211 (N–H str.), 1695
and 1663 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
1.08 (t, J = 7.2 Hz, 3H, OCH2CH3), 2.22 (s, 3H, CH3),
3.92 (q, J  = 7.2 Hz, 2H, OCH2CH3), 5.22 (s, 1H, CH),
7.12 (d, 2H, J  = 8.0 Hz, Ar-H), 7.34 (d, 2H, J  = 8.0 Hz,
Ar-H), 7.90 (s, 1H, NH-3), 9.12 (s, 1H, NH-1) ppm;
13C NMR (125 MHz, DMSO-d6) δ: 14.4, 17.8, 54.8,
60.0, 100.9, 122.5, 125.9, 129.7, 142.8, 146.7, 154.8,
166.2 ppm; MS(ESI): m/z  279 (M+H)+; Anal. calculated
for C14H15FN2O3: C, 60.43; H, 5.39; N, 10.07%; found:
C, 60.30; H, 5.36; N, 10.09%.sity for Science 8 (2014) 236–247
2.3.4.  5-Ethoxycarbonyl-6-methyl-4-(2-
chlorophenyl)-3,4-dihydropyrimidin-2(1H)-one  (4d)
IR (KBr, cm−1): 3312 and 3203 (N–H str.), 1686
and 1654 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
1.06 (t, J  = 7.2 Hz, 3H, OCH2CH3), 2.16 (s, 3H, CH3),
3.82 (q, J  = 7.2 Hz, 2H, OCH2CH3), 5.30 (s, 1H, CH),
7.16–7.38 (m, 4H, Ar-H), 8.00 (s, 1H, NH-3), 9.30 (s,
1H, NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ:
14.2, 17.4, 54.4, 60.9, 100.2, 122.2, 126.1, 129.4, 143.2,
146.2, 155.5, 166.4 ppm; MS(ESI): m/z  295 (M+H)+;
Anal. for C14H15ClN2O3 calculated: C, 57.05; H, 5.10;
N, 9.52%; found: C, 57.00; H, 5.06; N, 9.46%.
2.3.5. 5-Ethoxycarbonyl-6-methyl-4-(3-
bromophenyl)-3,4-dihydropyrimidin-2(1H)-one  (4e)
IR (KBr, cm−1): 3319 and 3211 (N–H str.), 1695
and 1664 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
1.08 (t, J  = 7.1 Hz, 3H, OCH2CH3), 2.18 (s, 3H, CH3),
3.78 (q, J  = 7.1 Hz, 2H, OCH2CH3), 5.28 (s, 1H, CH),
7.03–7.25 (m, 4H, Ar-H), 7.92 (s, 1H, NH-3), 9.04 (s,
1H, NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ:
13.9, 17.5, 54.3, 60.2, 100.4, 122.4, 126.3, 129.0, 143.4,
146.4, 155.1, 165.6 ppm; MS(ESI): m/z  339.9 (M+H)+;
Anal. for C14H15BrN2O3 calculated: C, 49.57; H, 4.43;
N, 8.26%; found: C, 49.47; H, 4.45; N, 8.22%.
2.3.6. 5-Ethoxycarbonyl-6-methyl-4-(4-
hydroxyphenyl)-3,4-dihydropyrimidin-
2(1H)-one  (4f)
IR (KBr, cm−1): 3384 (O–H str.), 3314 and 3203
(N–H str.), 1690 and 1664 (C O str.); 1H NMR
(500 MHz, DMSO-d6) δ: 1.08 (t, J  = 7.2 Hz, 3H,
OCH2CH3), 2.22 (s, 3H, CH3), 3.90 (q, J  = 7.2 Hz, 2H,
OCH2CH3), 5.24 (s, 1H, CH), 7.22 (d, 2H, J  = 8.0 Hz,
Ar-H), 7.44 (d, 2H, J  = 8.0 Hz, Ar-H), 7.82 (s, 1H, NH-
3), 9.12 (s, 1H, NH-1), 9.42 (s, 1H, OH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 14.2, 17.3, 54.1, 60.6, 100.6,
122.6, 126.2, 130.2, 143.6, 146.5, 155.3, 165.5 ppm;
MS(ESI): m/z  277 (M+H)+; Anal. for C14H16N2O4 cal-
culated: C, 60.87; H, 5.80; N, 10.14%; found: C, 60.89;
H, 5.81; N, 10.10%.
2.3.7. 5-Ethoxycarbonyl-6-methyl-4-(4-
methoxyphenyl)-3,4-dihydropyrimidin-
2(1H)-one  (4g)
IR (KBr, cm−1): 3321 and 3215 (N–H str.), 1700
and 1670 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
1.07 (t, J  = 7.2 Hz, 3H, OCH2CH3), 2.18 (s, 3H, CH3),
3.64 (s, 3H, OCH3), 3.94 (q, J  = 7.2 Hz, 2H, OCH2CH3),
5.28 (s, 1H, CH), 7.09 (d, 2H, J  = 8.2 Hz, Ar-H), 7.35 (d,
2H, J = 8.2 Hz, Ar-H), 7.92 (s, 1H, NH-3), 9.04 (s, 1H,
NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.3,
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8.0, 55.0, 60.4, 100.0, 121.9, 126.4, 130.3, 143.3, 146.2,
55.6, 166.3 ppm; MS(ESI): m/z  291 (M+H)+; Anal. for
15H18N2O4 calculated: C, 60.43; H, 5.39; N, 10.07%;
ound: C, 60.40; H, 5.34; N, 10.02%.
.3.8. 5-Ethoxycarbonyl-6-methyl-4-(3-
itrophenyl)-3,4-dihydropyrimidin-2(1H)-one  (4h)
IR (KBr, cm−1): 3314 and 3206 (N–H str.), 1690
nd 1659 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
.08 (t, J  = 7.2 Hz, 3H, OCH2CH3), 2.22 (s, 3H, CH3),
.84 (q, J  = 7.2 Hz, 2H, OCH2CH3), 5.22 (s, 1H, CH),
.07–7.33 (m, 4H, Ar-H), 8.18 (s, 1H, NH-3), 9.12 (s, 1H,
H-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.1,
8.1, 55.2, 60.5, 99.7, 121.8, 126.6, 129.5, 143.5, 145.7,
54.6, 165.8 ppm; MS(ESI): m/z  306 (M+H)+; Anal. for
14H15N3O5 calculated: C, 55.08; H, 4.92; N, 13.77%;
ound: C, 55.09; H, 4.90; N, 13.74%.
.3.9. 5-Ethoxycarbonyl-4-(2-furfuryl)-6-
ethyl-3,4-dihydropyrimidin-2(1H)-one  (4i)
IR (KBr, cm−1): 3376 and 3258 (N–H str.), 1706
nd 1665 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ:
.14 (t, J  = 7.4 Hz, 3H, OCH2CH3), 2.22 (s, 3H, CH3),
.98 (q, J  = 7.4 Hz, 2H, OCH2CH3), 5.12 (s, 1H, CH),
.78 (d, J  = 4.2 Hz, 1H), 7.00–7.08 (m, 2H), 7.22 (s, 1H,
H-3), 9.66 (s, 1H, NH-1) ppm; 13C NMR (125 MHz,
MSO-d6) δ:  13.9, 17.7, 45.2, 60.4, 106.6, 111.4, 117.9,
38.5, 139.6, 142.3, 160.2, 171.3 ppm; MS(ESI): m/z
51 (M+H)+; Anal. for C12H14N2O4 calculated: C,
7.59; H, 5.64; N, 11.19%; found: C, 57.48; H, 5.54;
, 11.22%.
.3.10.  5-Ethoxycarbonyl-6-methyl-4-propyl-3,4-
ihydropyrimidin-2(1H)-one  (4j)
IR (KBr, cm−1): 3354 and 3240 (N–H str.), 1712 and
658 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ: 1.07
t, J = 7.4 Hz, 3H, OCH2CH3), 1.14–1.27 (m, 7H), 2.18
s, 3H, CH3), 3.99 (q, J  = 7.4 Hz, 2H, OCH2CH3), 5.11
s, 1H, CH), 7.29 (s, 1H, NH-3), 9.74 (s, 1H, NH-1) ppm;
3C NMR (125 MHz, DMSO-d6) δ:  13.6, 14.5, 17.4,
8.2, 34.2, 46.1, 59.7, 109.6, 138.1, 160.2, 170.7 ppm;
S(ESI): m/z  227 (M+H)+; Anal. for C11H18N2O3 cal-
ulated: C, 58.39; H, 8.02; N, 12.38%; found: C, 58.33;
, 8.00; N, 12.34%.
.3.11.  4-Butyl-5-(ethoxycarbonyl)-6-methyl-3,4-
ihydropyrimidin-2(1H)-one  (4k)
IR (KBr, cm−1): 3354 and 3240 (N–H str.), 1712
1nd 1658 (C O str.); H NMR (500 MHz, DMSO-d6) δ:
.12 (t, J  = 7.4 Hz, 3H, OCH2CH3), 1.15–1.42 (m, 9H),
.26 (s, 3H, CH3), 3.94 (q, J  = 7.4 Hz, 2H, OCH2CH3),
.14 (s, 1H, CH), 7.22 (s, 1H, NH-3), 9.66 (s, 1H,sity for Science 8 (2014) 236–247 239
NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ:  13.8,
14.3, 18.1, 23.4, 26.8, 32.2, 46.3, 60.6, 111.4, 139.3,
162.2, 171.7 ppm; MS(ESI): m/z  241 (M+H)+; Anal. for
C12H20N2O3 calculated: C, 59.98; H, 8.39; N, 11.66%;
found: C, 59.88; H, 8.37; N, 11.64%.
2.3.12. 5-Methoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-one  (4l)
IR (KBr, cm−1): 3323 and 3214 (N–H str.), 1697 and
1665 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ: 2.18
(s, 3H, CH3), 3.52 (s, 3H, OCH3), 5.28 (s, 1H, CH),
7.02–7.59 (m, 4H, Ar-H), 7.98 (s, 1H, NH-3), 9.22 (s,
1H, NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ:
14.5, 17.1, 55.1, 100.7, 122.0, 125.7, 129.8, 143.7, 145.9,
154.9, 165.7 ppm; MS(ESI): m/z  247 (M+H)+; Anal. for
C13H14N2O3 calculated: C, 63.41; H, 5.69; N, 11.38%;
found: C, 63.33; H, 5.66; N, 11.36%.
2.3.13. 5-Methoxycarbonyl-6-methyl-4-(4-
methoxyphenyl)-3,4-dihydropyrimidin-2(1H)-one
(4m)
IR (KBr, cm−1): 3313 and 3204 (N–H str.), 1690
and 1656 (C O str.); 1H NMR (500 MHz, DMSO-d6)
δ: 2.24 (s, 3H, CH3), 3.62 (s, 3H, OCH3), 3.71 (s, 3H,
OCH3), 5.14 (s, 1H, CH), 7.16 (d, 2H, J  = 8.0 Hz, Ar-
H), 7.25 (d, 2H, J = 8.0 Hz, Ar-H), 7.89 (s, 1H, NH-3),
9.18 (s, 1H, NH-1) ppm; 13C NMR (125 MHz, CDCl3)
δ: 13.8, 17.4, 54.9, 100.7, 122.8, 126.1, 129.2, 142.6,
145.8, 155.3, 166.4 ppm; MS(ESI): m/z  277 (M+H)+;
Anal. for C14H16N2O4 calculated: C, 60.87; H, 5.80; N,
10.14%; found: C, 60.77; H, 5.75; N, 10.08%.
2.3.14.  5-Methoxycarbonyl-6-methyl-4-(4-
chlorophenyl)-3,4-dihydropyrimidin-2(1H)-one  (4n)
IR (KBr, cm−1): 3316 and 3221 (N–H str.), 1696 and
1656 (C O str.); 1H NMR (500 MHz, DMSO-d6) δ: 2.11
(s, 3H, CH3), 3.66 (s, 3H, OCH3), 5.33 (s, 1H, CH), 7.07
(d, 2H, J = 8.0 Hz, Ar-H), 7.35 (d, 2H, J  = 8.0 Hz, Ar-H),
8.00 (s, 1H, NH-3), 9.22 (s, 1H, NH-1) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 14.0, 17.5, 54.5, 100.7, 122.5,
126.5, 130.3, 142.8, 146.0, 155.5, 166.6 ppm; MS(ESI):
m/z 281 (M+H)+; Anal. for C13H13ClN2O3 calculated:
C, 55.62; H, 4.63; N, 9.98%; found: C, 55.55; H, 4.65;
N, 9.95%.
2.3.15.  5-Methoxycarbonyl-6-methyl-4-(4-hydro-
xyphenyl)-3,4-dihydropyrimidin-2(1H)-one  (4o)
−1IR (KBr, cm ): 3377 (O–H str.), 3318 and 3219
(N–H str.), 1692 and 1670 (C O str.); 1H NMR
(500 MHz, DMSO-d6) δ: 2.24 (s, 3H, CH3), 3.61 (s,
3H, OCH3), 5.18 (s, 1H, CH), 7.13 (d, 2H, J  = 8.2 Hz,
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Ar-H), 7.39 (d, 2H, J  = 8.2 Hz, Ar-H), 7.78 (s, 1H, NH-
3), 9.29 (s, 1H, NH-1), 9.55 (s, 1H, OH) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 14.2, 17.7, 54.7, 100.7, 122.5,
126.0, 129.6, 142.9, 146.3, 154.4, 165.5 ppm; MS(ESI):
m/z 263 (M+H)+; Anal. for C13H14N2O4 calculated: C,
59.54; H, 5.34; N, 10.68%; found: C, 59.44; H, 5.30; N,
10.62%.
2.3.16.  5-Ethoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-thione  (4p)
IR (KBr, cm−1): 3328 and 3209 (N–H str.), 1702
(C O str.), 1202 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 1.03 (t, J = 7.4 Hz, 3H, OCH2CH3), 2.17 (s,
3H, CH3), 4.02 (q, J = 7.4 Hz, 2H, OCH2CH3), 5.11
(s, 1H, CH), 7.21–7.41 (m, 5H, Ar-H), 7.16 (s, 1H,
NH-3), 9.57 (s, 1H, NH-1) ppm; 13C NMR (125 MHz,
DMSO-d6) δ:  14.4, 18.0, 54.6, 60.1, 99.9, 122.4, 125.9,
129.8, 143.0, 154.6, 165.7, 174.7 ppm; MS(ESI): m/z
277 (M+H)+; Anal. for C14H16N2O2S calculated: C,
60.87; H, 5.79; N, 10.14%; found: C, 60.83; H, 5.73; N,
10.13%.
2.3.17.  5-Ethoxycarbonyl-6-methyl-4-(4-
methoxyphenyl)-3,4-dihydropyrimidin-
2(1H)-thione  (4q)
IR (KBr, cm−1): 3323 and 3206 (N–H str.), 1697
(C O str.), 1209 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 1.20 (t, J  = 7.4 Hz, 3H, OCH2CH3), 2.19 (s, 3H,
CH3), 3.58 (s, 3H, OCH3), 3.99 (q, J  = 7.4 Hz, 2H,
OCH2CH3), 5.26 (s, 1H, CH), 7.11 (s, 1H, NH-3), 7.01
(d, 2H, J  = 8.0 Hz, Ar-H), 7.36 (d, 2H, J  = 8.0 Hz, Ar-
H), 9.56 (s, 1H, NH-1) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 14.6, 17.2, 54.2, 60.8, 99.5, 122.2, 126.3,
129.6, 143.3, 155.8, 166.0, 175.5 ppm; MS(ESI): m/z
307 (M+H)+; Anal. for C15H18N2O3S calculated: C,
58.82; H, 5.88; N, 9.15%; found: C, 58.72; H, 5.85; N,
9.12%.
2.3.18.
5-Ethoxycarbonyl-6-methyl-4-(2-thienyl)-3,4-
dihydropyrimidin-2(1H)-thione (4r)
IR (KBr, cm−1): 3368 and 3244 (N–H str.), 1688
(C O str.), 1258 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 1.12 (t, J  = 7.4 Hz, 3H, OCH2CH3), 2.25 (s, 3H,
CH3), 4.06 (q, J  = 7.4 Hz, 2H, OCH2CH3), 5.18 (s, 1H,
CH), 6.95–7.01 (m, 2H), 7.22 (s, 1H, NH-3), 7.41 (d,
13J = 4.2 Hz, 1H), 9.66 (s, 1H, NH-1) ppm; C NMR
(125 MHz, DMSO-d6) δ:  14.3, 17.8, 53.2, 59.7, 104.6,
121.4, 126.9, 129.5, 138.6, 142.4, 164.2, 175.7 ppm;
MS(ESI): m/z  283 (M+H)+; Anal. for C12H14N2O2S2sity for Science 8 (2014) 236–247
calculated: C, 51.04; H, 5.00; N, 9.92%; found: C, 51.00;
H, 4.95; N, 9.95%.
2.3.19. 5-Methoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-thione  (4s)
IR (KBr, cm−1): 3310 and 3201 (N–H str.), 1686
(C O str.), 1196 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 2.11(s, 3 H, CH3), 3.66 (s, 3H, OCH3), 5.19 (s, 1H,
CH), 7.00–7.28 (m, 5H, Ar-H): 7.43 (s, 1H, NH-3), 9.26
(s, 1H, NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ:
13.7, 17.1, 54.4, 100.1, 122.2, 126.4, 129.6, 143.5, 155.4,
165.4, 174.9 ppm; MS(ESI): m/z  263 (M+H)+; Anal. for
C13H14N2O2S calculated: C, 59.54; H, 5.34; N, 10.69%;
found: C, 59.44; H, 5.32; N, 10.64%.
2.3.20. 5-Methoxycarbonyl-6-methyl-4-
(4-chlorophenyl)-3,4-
dihydropyrimidin-2(1H)-thione  (4t)
IR (KBr, cm−1): 3321 and 3212 (N–H str.), 1689
(C O str.), 1206 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 2.18 (s, 3 H, CH3), 3.55 (s, 3H, OCH3), 5.21
(s, 1H, CH), 7.13 (d, 2H, J  = 8.2 Hz, Ar-H), 7.33 (d,
2H, J = 8.2 Hz, Ar-H), 7.55 (s, 1H, NH-3), 9.33 (s, 1H,
NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.3,
17.7, 54.0, 100.5, 122.1, 126.1, 129.4, 143.0, 155.2,
165.3, 175.2 ppm; MS(ESI): m/z  297 (M+H)+; Anal.
for C13H13ClN2O2S calculated: C, 52.62; H, 4.38; N,
9.44%; found: C, 52.55; H, 4.33; N, 9.44%.
2.3.21.  5-Methoxycarbonyl-6-methyl-4-(2-
nitrophenyl)-3,4-dihydropyrimidin-2(1H)-
thione (4u)
IR (KBr, cm−1): 3311 and 3202 (N–H str.), 1698
(C O str.), 1208 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 2.26 (s, 3 H, CH3), 3.58 (s, 3H, OCH3), 5.28 (s, 1H,
CH), 7.18–7.40 (m, 4H, Ar-H), 7.63 (s, 1H, NH-3), 9.17
(s, 1H, NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ:
14.4, 18.2, 54.7, 100.4, 122.0, 126.6, 129.5, 143.2, 154.9,
166.5, 174.3 ppm; MS(ESI): m/z  308 (M+H)+; Anal. for
C13H13N3O4S calculated: C, 50.81; H, 4.23; N, 13.68%;
found: C, 50.75; H, 4.20; N, 13.66%.
2.3.22. 5-Methoxycarbonyl-6-methyl-4-(4-
ﬂuorophenyl)-3,4-dihydropyrimidin-2(1H)-
thione (4v)
IR (KBr, cm−1): 3314 and 3213 (N–H str.), 1688
(C O str.), 1206 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 2.14 (s, 3 H, CH3), 3.44 (s, 3H, OCH3), 5.27
(s, 1H, CH), 7.10 (d, 2H, J  = 8.0 Hz, Ar-H), 7.30 (d,
2H, J = 8.0 Hz, Ar-H), 7.53 (s, 1H, NH-3), 9.24 (s, 1H,
NH-1) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 14.4,
17.8, 54.5, 100.8, 121.9, 126.0, 129.0, 143.1, 154.7,
 Univer
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66.7, 175.8 ppm; MS(ESI): m/z  281 (M+H)+; Anal.
or C13H13FN2O2S calculated: C, 55.71; H, 4.64; N,
0.00%; found: C, 55.66; H, 4.60; N, 10.03%.
.4.  General  procedure  for  the  preparation  of
-aryl-
,4-dihydro-1H-indeno[1,2-d]pyrimidine-2,5-diones
nd 4-aryl-2-thioxo-1,2,3,4-tetrahydro-indeno[1,2-
]pyrimidine-5-ones
A mixture of aldehyde (1 mmol), 2H-indene-1,3-
ione (1 mmol), urea (1.5 mmol) and DBSA (5 mol%)
as heated under solvent-free condition to 80 ◦C, with
tirring, for 2.5–3.5 h to completion of the reaction
monitored by thin-layer chromatography). After cool-
ng to room temperature, the reaction was quenched with
0 ml H2O and stirred for 10 min. The pure product was
solated by filtration, followed by washing with ethyl
cetate. The IR, 1H NMR, 13C NMR, mass and elemental
pectra of the synthesized compounds are given below.
.5.  Spectral  data  for  the  synthesized  compounds
6a–l)
.5.1.  4-Phenyl-3,4-dihydro-1H-indeno[1,2-
]pyrimidine-2,5-
ione (6a)
IR (KBr, cm−1): 3388 and 3268 (N–H str.), 1688
nd 1661 (C O str.); 1H NMR (500 MHz, DMSO-d6)
: 5.11 (s, 1H, CH), 7.07–7.30 (m, 5H, Ar-H), 7.51–7.67
m, 4H, Ar-H), 7.81 (s, 1H, NH-1), 9.40 (s, 1H, NH-3)
pm; 13C NMR (125 MHz, DMSO-d6) δ: 48.1, 107.2,
26.1, 126.6, 127.4, 128.3, 128.8, 129.3, 134.2, 134.6,
36.4, 142.3, 142.7, 155.9, 189.1 ppm; MS(ESI): m/z
77 (M+H)+; Anal. for C17H12N2O2 calculated: C,
3.91; H, 4.35; N, 10.14%; found: C, 73.83; H, 4.28;
, 10.13%.
.5.2.  4-(3-Nitrophenyl)-3,4-dihydro-1H-
ndeno[1,2-d]pyrimidine-2,5-dione  (6b)
IR (KBr, cm−1): 3380 and 3275 (N–H str.), 1685
nd 1669 (C O str.); 1H NMR (500 MHz, DMSO-d6)
: 5.17 (s, 1H, CH), 7.11–7.28 (m, 4H, Ar-H), 7.49–7.62
m, 4H, Ar-H), 7.83 (s, 1H, NH-1), 9.33 (s, 1H, NH-3)
pm; 13C NMR (125 MHz, DMSO-d6) δ: 48.3, 107.5,
26.4, 126.9, 127.6, 128.6, 128.9, 129.4, 134.4, 134.7,
36.5, 142.5, 142.9, 156.2, 188.7 ppm; MS(ESI): m/z
22 (M+H)+; Anal. for C17H11N3O4 calculated: C,
3.55; H, 3.43; N, 13.08%; found: C, 63.43; H, 3.40;
, 13.01%.sity for Science 8 (2014) 236–247 241
2.5.3.  4-(4-Chlorophenyl)-3,4-dihydro-1H-
indeno[1,2-d]pyrimidine-2,5-dione  (6c)
IR (KBr, cm−1): 3384 and 3264 (N–H str.), 1680
and 1663 (C O str.); 1H NMR (500 MHz, DMSO-d6)
δ: 5.20 (s, 1H, CH), 7.15 (d, 2H, J  = 8.2 Hz, Ar-H),
7.32 (d, 2H, J = 8.2 Hz, Ar-H), 7.55–7.68 (m, 4H, Ar-H),
7.85 (s, 1H, NH-1), 9.38 (s, 1H, NH-3) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 48.4, 107.3, 126.2, 126.7,
127.7, 128.5, 128.9, 129.3, 134.3, 134.6, 136.2, 142.3,
142.6, 156.4, 188.8 ppm; MS(ESI): m/z  311 (M+H)+;
Anal. for C17H11ClN2O2 calculated: C, 65.71; H, 3.54;
N, 9.02%; found: C, 65.65; H, 3.50; N, 9.03%.
2.5.4. 4-(2-Chlorophenyl)-3,4-dihydro-1H-
indeno[1,2-d]pyrimidine-2,5-dione  (6d)
IR (KBr, cm−1): 3373 and 3273 (N–H str.), 1682
and 1666 (C O str.); 1H NMR (500 MHz, DMSO-d6)
δ: 5.15 (s, 1H, CH), 7.09–7.34 (m, 4H, Ar-H), 7.48–7.64
(m, 4H, Ar-H), 7.80 (s, 1H, NH-1), 9.41 (s, 1H, NH-3)
ppm; 13C NMR (125 MHz, DMSO-d6) δ: 47.9, 107.4,
126.0, 126.8, 127.3, 128.2, 128.8, 129.5, 134.5, 134.8,
136.4, 142.1, 142.7, 155.8, 188.6 ppm; MS(ESI): m/z
311.4 (M+H)+; Anal. for C17H11ClN2O2 calculated: C,
65.71; H, 3.54; N, 9.02%; found: C, 65.62; H, 3.48; N,
8.96%.
2.5.5. 4-Phenyl-2-thioxo-1,2,3,4-tetrahydro-
indeno[1,2-d]pyrimidine-5-one  (6e)
IR (KBr, cm−1): 3406 and 3280 (N–H str.), 1672
(C O str.), 1194 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 5.24 (s, 1H, CH), 7.13–7.34 (m, 5H, Ar-H),
7.55–7.67 (m, 4H, Ar-H), 7.91 (s, 1H, NH-1), 9.16 (s, 1H,
NH-3) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 46.3,
105.2, 124.2, 125.3, 126.2, 127.6, 128.4, 129.3, 134.0,
135.6, 136.2, 142.3, 144.5, 183.3, 188.7 ppm; MS(ESI):
m/z 293 (M+H)+; Anal. for C17H12N2OS calculated: C,
69.86; H, 4.11; N, 9.59%; found: C, 69.80; H, 4.06; N,
9.57%.
2.5.6. 4-(4-Nitrophenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6f)
IR (KBr, cm−1): 3411 and 3277 (N–H str.), 1677
(C O str.), 1187 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 5.20 (s, 1H, CH), 7.05 (d, 2H, J  = 8.0 Hz, Ar-H),
7.29 (d, 2H, J = 8.0 Hz, Ar-H), 7.57–7.70 (m, 4H, Ar-H),
7.98 (s, 1H, NH-1), 9.22 (s, 1H, NH-3) ppm; 13C NMR
(125 MHz, DMSO-d6) δ: 46.7, 104.8, 124.5, 125.5,
126.4, 127.8, 128.6, 129.5, 134.4, 135.3, 136.3, 141.9,
144.3, 183.5, 189.1 ppm; MS(ESI): m/z  338 (M+H)+;
Anal. for C17H11N3O3S calculated: C, 60.53; H, 3.26;
N, 12.46%; found: C, 60.44; H, 3.22; N, 12.40%.
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2.5.7.  4-(4-Methylphenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6g)
IR (KBr, cm−1): 3405 and 3274 (N–H str.), 1669
(C O str.), 1189 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 2.16 (s, 3H, CH3), 5.23 (s, 1H, CH), 7.11 (d,
2H, J  = 8.1 Hz, Ar-H), 7.31 (d, 2H, J = 8.1 Hz, Ar-H),
7.54–7.67 (m, 4H, Ar-H), 7.97 (s, 1H, NH-1), 9.21 (s, 1H,
NH-3) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 17.1,
46.2, 105.3, 124.4, 125.4, 126.3, 127.7, 128.5, 129.4,
134.5, 135.5, 136.5, 141.9, 144.4, 183.4, 189.3 ppm;
MS(ESI): m/z  307 (M+H)+; Anal. for C18H14N2OS cal-
culated: C, 70.59; H, 4.58; N, 9.15%; found: C, 70.53;
H, 4.51; N, 9.10%.
2.5.8.  4-(2-Chlorophenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6h)
IR (KBr, cm−1): 3413 and 3283 (N–H str.), 1678
(C O str.), 1190 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 5.17 (s, 1H, CH), 7.02–7.25 (m, 4H, Ar-H),
7.49–7.61 (m, 4H, Ar-H), 7.90 (s, 1H, NH-1), 9.17 (s, 1H,
NH-3) ppm; 13C NMR (125 MHz, DMSO-d6) δ:  46.6,
104.9, 124.6, 125.6, 126.5, 127.5, 128.7, 129.6, 134.7,
135.7, 136.4, 141.8, 144.2, 183.2, 188.7 ppm; MS(ESI):
m/z 327 (M+H)+; Anal. for C17H11ClN2OS calculated:
C, 62.49; H, 3.37; N, 8.58%; found: C, 62.44; H, 3.35;
N, 8.53%.
2.5.9.  4-(3-Nitrophenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6i)
IR (KBr, cm−1): 3401 and 3287 (N–H str.), 1675
(C O str.), 1193 (C S str.); 1H NMR (500 MHz,
DMSO-d6) δ: 5.16 (s, 1H, CH), 7.04–7.30 (m, 4H, Ar-H),
7.50–7.71 (m, 4H, Ar-H), 7.97 (s, 1H, NH-1), 9.19 (s, 1H,
NH-3) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 46.4,
105.2, 124.7, 125.7, 126.4, 127.6, 128.8, 129.8, 134.6,
135.2, 136.6, 142.4, 144.6, 183.0, 189.0 ppm; MS(ESI):
m/z 338 (M+H)+; Anal. for C17H11N3O3S calculated: C,
60.53; H, 3.26; N, 12.46%; found: C, 60.47; H, 3.20; N,
12.44%.
2.5.10.  4-(3-Bromophenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6j)
IR (KBr, cm−1): 3410 and 3279 (N–H str.), 1670
(C O str.), 1185 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 5.20 (s, 1H, CH), 7.11–7.29 (m, 4H, Ar-H),
7.53–7.72 (m, 4H, Ar-H), 7.95 (s, 1H, NH-1), 9.21 (s,
131H, NH-3) ppm; C NMR (125 MHz, DMSO-d6) δ:
46.3, 104.8, 124.4, 125.2, 126.7, 127.7, 128.4, 129.7,
134.1, 135.1, 136.2, 142.6, 144.0, 183.6, 189.2 ppm;
MS(ESI): m/z  371.9 (M+H)+; Anal. for C17H11BrN2OSsity for Science 8 (2014) 236–247
calculated: C, 55.00; H, 2.96; N, 7.55%; found: C, 54.93;
H, 2.93; N, 7.51%.
2.5.11. 4-(4-Methoxyphenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6k)
IR (KBr, cm−1): 3403 and 3286 (N–H str.), 1680
(C O str.), 1186 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 3.60 (s, 3H, OCH3), 5.23 (s, 1H, CH), 7.10 (d,
2H, J  = 8.2 Hz, Ar-H), 7.37 (d, 2H, J = 8.2 Hz, Ar-H),
7.48–7.66 (m, 4H, Ar-H), 7.91 (s, 1H, NH-1), 9.23 (s, 1H,
NH-3) ppm; 13C NMR (125 MHz, DMSO-d6) δ: 46.6,
55.3, 105.2, 124.5, 125.3, 126.6, 127.5, 128.6, 129.7,
134.3, 135.3, 136.5, 142.2, 144.5, 183.7, 188.8 ppm;
MS(ESI): m/z  323 (M+H)+; Anal. for C18H14N2O2S cal-
culated: C, 67.08; H, 4.35; N, 8.70%; found: C, 67.02;
H, 4.31; N, 8.63%.
2.5.12. 4-(2-Methylphenyl)-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-one  (6l)
IR (KBr, cm−1): 3404 and 3276 (N–H str.), 1674
(C O str.), 1189 (C S str.); 1H NMR (500 MHz, DMSO-
d6) δ: 2.21 (s, 3H, CH3), 5.19 (s, 1H, CH), 7.06–7.30
(m, 4H, Ar-H), 7.49–7.63 (m, 4H, Ar-H), 7.90 (s, 1H,
NH-1), 9.18 (s, 1H, NH-3) ppm; 13C NMR (125 MHz,
DMSO-d6) δ: 17.4, 46.8, 104.9, 124.6, 125.6, 126.3,
127.9, 128.5, 129.5, 134.5, 135.7, 136.2, 142.3, 144.3,
183.3, 189.4 ppm; MS(ESI): m/z  307 (M+H)+; Anal. for
C18H14N2OS calculated: C, 70.59; H, 4.58; N, 9.15%;
found: C, 70.55; H, 4.54; N, 9.13%.
3.  Results  and  discussion
We synthesized various analogues of dihydropy-
rimidines from aldehydes with ethylacetoacetate or
methylacetoacetate and urea or thiourea. We started
our study of one-pot three-component Biginelli con-
densation by using DBSA as the catalyst (Scheme 1)
and examining the conditions for the reaction with
benzaldehyde, ethylacetoacetate and urea to afford the
corresponding DHPM product.
One important aspect of green chemistry is the
elimination of solvents in chemical processes or the
replacement of hazardous solvents with relatively benign
solvents [40]. Our initial work started with screening of
solvent and catalyst loading so as to identify optimal
reaction conditions for the synthesis of DHPM deriva-
tives. The solvents acetonitrile, dioxane, acetic acid,
water and ethanol were examined (Table 1), and reac-
◦tions with no solvent at 80 C were found to be the
most successful. We also evaluated the amount of DBSA
required for the reaction. Decreasing the concentration
of catalyst from 5 mol% to 3 mol% decreased the yield
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Scheme 1. DBSA-catalyzed synthesis
rom 94% to 73%, while increasing the concentration
rom 5 mol% to 10 mol% did not change the yield. As
se of 5 mol% of DBSA maintained the yield at 94%,
his amount is sufficient to promote the reaction.
To determine the scope of these conditions, we syn-
hesized derivatives of 3,4-dihydropyrimidin-2(1H)-one
nd -thione from either ethylacetoacetate or methylace-
oacetate and either urea or thiourea in the presence
f DBSA. The results are presented in Table 2.
ll the reactions involving o-, m- and p-substituted
enzaldehydes proceeded smoothly and afforded the
orresponding 3,4-dihydropyrimidin-2(1H)-one in mod-
rate to high yields. Electronic effects were observed:
enzaldehydes with an electron-donating group required
onger reaction times to yields, while those with an
lectron-withdrawing group gave clearly higher yields.
-Substituted benzaldehydes afforded the correspond-
ng 3,4-dihydropyrimidin-2(1H)-one in relatively lower
ields, whether they had an electron-donating or an
lectron-withdrawing group, indicating a steric effect.
he behaviour of thiourea was similar to that of urea
Scheme 1).
able 1
ynthesis of 3,4-dihydropyrimidin-2(1H)-one: solvent screening and catalyst
ntry Solvent Temperature (◦C) Amou
 Acetonitrile Reflux 5 
 Dioxane Reflux 5 
 Acetic acid Reflux 5 
 Water Reflux 5 
 Ethanol Reflux 5 
 Solvent-free 80 5 
 Solvent-free 80 3 
 Solvent-free 80 10 
a Reaction conditions: benzaldehyde (1 mmol), ethylacetoacetate (1 mmol
arious solvents (5 ml) and also heated at 80 ◦C under solvent-free conditions
b Isolated yields.ihydropyrimidin-2(1H)-ones/thiones.
To explore the advantages of DBSA-catalyzed syn-
thesis of 3,4-dihydropyrimidin-2(1H)-one, we compared
the results obtained under our optimized conditions
with those reported in the literature with other catalysts
(Table 3). DBSA was found to be superior in terms
of yield and reaction time to the solid acid catalysts
copper(II) sulfamate, zeolite-supported hetero-polyacid,
Nafion-H, p-sulfonic acid calixarenes, triphenyl phos-
phine, silica sulfuric acid, bioglycerol-based carbon,
montmorillonite KSF, cellulose sulfuric acid, quartz or
granite and ruthenium(III) chloride.
The possibility of recycling the catalyst was exam-
ined in the model reaction for the synthesis of
3,4-dihydropyrimidin-2(1H)-one under the optimized
conditions. Upon completion of the reaction, the mix-
ture was poured onto crushed ice with stirring. The crude
product was filtered, washed with cold water and recrys-
tallized from hot ethanol. The catalyst was recovered as
described in Section 2, and the recycling ability of the
catalyst was tested for further runs. As shown in Fig. 1,
the yields when recycled catalyst was used for further
runs were 88–94%.
 loading.a
nt of catalyst (mol %) Time (h) Yield (%)b
5.0 68
5.0 63
5.0 71
5.0 60
5.0 58
3.0 94
3.0 73
3.0 94
), and urea (1.5 mmol) were refluxed in the presence of DBSA with
.
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Table 2
DBSA-catalyzed synthesis of 3,4-dihydropyrimidin-2(1H)-ones and -thiones.a
Entry R1 OR X Product Time (h) Yield (%)b Mp (◦C)
Found Reported
1 C6H5 OEt O 4a 3.0 94 200–202 202–203 [22]
2 2-NO2-C6H4 OEt O 4b 2.5 81 205–207 206–208 [13]
3 4-F-C6H4 OEt O 4c 2.5 93 176–178 174–176 [13]
4 2-Cl-C6H4 OEt O 4d 2.5 84 212–214 213–216 [18]
5 3-Br-C6H4 OEt O 4e 2.5 88 183–185 182–184 [16]
6 4-OH-C6H4 OEt O 4f 2.5 93 195–198 196–197 [25]
7 4-OCH3-C6H4 OEt O 4g 3.0 86 202–204 203–204 [22]
8 3-NO2-C6H4 OEt O 4h 2.5 90 224–226 226–228 [22]
9 2-Furfuryl OEt O 4i 3.0 89 202–204 205–206 [20]
10 n-C3H7 OEt O 4j 3.0 87 155–157 157–158 [24]
11 n-C4H9 OEt O 4k 3.0 88 155–157 156–158 [27]
12 C6H5 OMe O 4l 3.0 89 212–214 210–213 [18]
13 4-OCH3-C6H4 OMe O 4m 3.0 86 191–194 190–192 [18]
14 4-Cl-C6H4 OMe O 4n 2.5 94 205–206 204–206 [18]
15 4-OH-C6H4 OMe O 4o 2.5 90 240–242 241–242 [16]
16 C6H5 OEt S 4p 3.0 88 208–210 210–211 [25]
17 4-OCH3-C6H4 OEt S 4q 3.0 85 155–157 154–156 [13]
18 2-Thienyl OEt S 4r 3.0 85 215–217 214–216 [27]
19 C6H5 OMe S 4s 3.0 87 220–222 –
20 4-Cl-C6H4 OMe S 4t 2.5 89 184–186 –
21 2-NO2-C6H4 OMe S 4u 2.5 81 194–196 –
22 4-F-C6H4 OMe S 4v 2.5 94 208–210 –
aReaction conditions: aldehydes (1 mmol), ethylacetoacetate (1 mmol), and urea/thiourea (1.5 mmol) heating at 80 ◦C in the presence of DBSA
under solvent-free condition.
bIsolated yield.
During synthesis of 3,4-dihydropyrimidin-2(1H)-
ones and -thiones, we found that several compounds
were synthesized smoothly in the presence of DBSA. We
therefore used the same reaction conditions to synthesize
a new series of 4-aryl-3,4-dihydro-1H-indeno[1,2-
d]pyrimidine-2,5-diones and 4-aryl-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-ones. A mixture
of benzaldehyde (1a), 2H-indene-1,3-dione (5) and urea
(3a) at a molar ratio of 1:1:1.5 in the presence of 5 mol%
O
O
NH2
H2N X
SO
O
CH
So
+ +
351
X = O,  S
R1-CHO
Scheme 2. DBSA-catalyzed synthesis of various substituted 4-aryl-3,4-dihy
tetrahydro-indeno[1,2-d]pyrimidine-5-ones.DBSA under solvent-free condition was heated at 80 ◦C
for 2.5 h. To our delight, the desired product 6a was
obtained in 91% yield (Scheme 2). Encouraged by this
result, a series of aldehydes was selected for the conden-
sation reaction (Table 4).
As shown in Table 4, aromatic aldehydes bearing
functional groups (for example H, CH3, OCH3,
Cl, NO2 and Br) reacted smoothly with urea
or thiourea and 2H-indene-1,3-dione to give the
R1
NH
N
H
O
X
O
H
2(CH2)10CH3
DBSA  (5  mol%)
lven t-fre e,   80 oC
l-a6
dro-1H-indeno[1,2-d]pyrimidine-2,5-diones/4-aryl-2-thioxo-1,2,3,4-
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Table 3
Comparison of catalytic activity of DBSA with other catalysts reported in the literature for the synthesis of 3,4-dihydropyrimidinones.
Entry Catalyst Conditions Time (h) Yield (%) Ref
1 Copper(II) Sulfamate Acetic acid/100 ◦C 6.0 79 [16]
2 Zeolite-supported HPA CH3CN/Reflux 10.0 84 [21]
3 Nafion-H EtOH/Reflux 4.0 94 [25]
4 p-Sulfonic acid calixarenes EtOH/Reflux 8.0 81 [15]
5 Triphenyl phosphine Solvent-free/100 ◦C 10.0 70 [17]
6 Silica sulfuric acid EtOH/Reflux 6.0 91 [24]
7 Bioglycerol based carbon CH3CN/75–80 ◦C 6.0 91 [14]
8 Montmorillonite KSF Solvent-free/100 ◦C 48.0 77 [19]
9 Cellulose sulfuric acid H2O/100 ◦C 5.0 80 [12]
10 Quartz EtOH/Reflux 3.0 68 [20]
11 Granite EtOH/Reflux 3.5 64 [20]
12 RuCl3 Solvent-free/100 ◦C 0.5 91 [23]
13 DBSA Solvent-free/80 ◦C 3.0 94 Present work
Table 4
DBSA-catalyzed synthesis of various substituted 4-aryl-3,4-dihydro-1H-indeno[1,2-d]pyrimidine-2,5-diones/4-aryl-2-thioxo-1,2,3,4-tetrahydro-
indeno[1,2-d]pyrimidine-5-ones.a
Entry R1 X Product Time (h) Yield (%)b Mp (◦C)
1 C6H5 O 6a 2.5 91 208–210
2 3-NO2-C6H4 O 6b 2.5 90 216–218
3 4-Cl-C6H4 O 6c 2.5 92 196–198
4 2-Cl-C6H4 O 6d 3.0 88 184–186
5 C6H5 S 6e 3.0 89 212–214
6 4-NO2-C6H4 S 6f 2.5 92 220–222
7 4-CH3-C6H4 S 6g 3.5 88 200–202
8 2-Cl-C6H4 S 6h 3.5 87 190–192
9 3-NO2-C6H4 S 6i 3.0 90 198–200
10 3-Br-C6H4 S 6j 3.0 91 204–206
11 4-OCH3-C6H4 S 6k 3.5 88 226–228
12 2-CH3-C6H4 S 6l 3.5 87 202–204
aReaction conditions: substituted benzaldehydes (1 mmol), 2H-indene-1,3-dione (1 mmol) and urea/thiourea (1.5 mmol) heating at 80 ◦C in the
presence of DBSA under solvent-free condition.
bIsolated yield.
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Fig. 1. Recycling of catalyst DBSA for the synthesis of 3,4-
dihydropyrimidin-2(1H)-one.corresponding products in good yields. This condensa-
tion reaction was complete within 2.5–3.5 h.
4.  Conclusions
We describe here an efficient method for the
synthesis of 3,4-dihydropyrimidinones and thiones
in a DBSA-catalyzed reaction of aldehydes, ethy-
lacetoacetate or methylacetoacetate, and urea or
thiourea under solvent-free condition at 80 ◦C. The
reaction is one-pot and can be performed easily;
it is therefore a practical, environmentally accept-
able method for synthesizing 3,4-dihydro pyrimidi-
nones and -thiones. 4-Aryl-3,4-dihydro-1H-indeno[1,2-
d]pyrimidine-2,5-diones and 4-aryl-2-thioxo-1,2,3,4-
tetrahydro-indeno[1,2-d]pyrimidine-5-ones were also
synthesized under the same conditions by the
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Biginelli-like reaction of 2H-indene-1,3-dione with urea
or thiourea and aromatic aldehydes.
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